HANXBIO-B Shares Surge in Afternoon Trading Following Index Inclusion and Key Research Presentations

Stock News

Jun 24

Shares of HANXBIO-B (HKEX: 03378) rose nearly 7% during the afternoon session. As of the latest update, the stock was up 6.99% to HK$28.48, with a turnover of HK$9.56 million.

The upward movement follows recent company announcements. HANXBIO-B disclosed that, based on the quarterly review results for the FTSE Global Equity Index Series by FTSE Russell, the company has been added to the FTSE Global Micro Cap Index. This inclusion officially took effect after the market close on Friday, June 19, 2026.

Prior to this development, HANXBIO-B presented four key preclinical research findings at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The showcased research included the CTLA-4/SIRPα bifunctional fusion protein HX044, the bispecific antibody-drug conjugate (BsAbADC) HX116, the PD-L1-targeting ADC HX112, and a 3D tumor organoid ADC evaluation platform. These presentations further demonstrated the company's research and development capabilities and innovative potential.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1147220059"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147220059\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147220059?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 14:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147220059","market":"us","top_or_hot":-1,"title":"HANXBIO-B Shares Surge in Afternoon Trading Following Index Inclusion and Key Research Presentations","media":"Stock News","content":"<p>Shares of <b>HANXBIO-B</b> (<b>HKEX: 03378</b>) rose nearly 7% during the afternoon session. As of the latest update, the stock was up 6.99% to HK$28.48, with a turnover of HK$9.56 million.<br><br>The upward movement follows recent company announcements. <b>HANXBIO-B</b> disclosed that, based on the quarterly review results for the FTSE Global Equity Index Series by FTSE Russell, the company has been added to the FTSE Global Micro Cap Index. This inclusion officially took effect after the market close on Friday, June 19, 2026.<br><br>Prior to this development, <b>HANXBIO-B</b> presented four key preclinical research findings at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The showcased research included the CTLA-4/SIRPα bifunctional fusion protein HX044, the bispecific antibody-drug conjugate (BsAbADC) HX116, the PD-L1-targeting ADC HX112, and a 3D tumor organoid ADC evaluation platform. These presentations further demonstrated the company's research and development capabilities and innovative potential.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HANXBIO-B Shares Surge in Afternoon Trading Following Index Inclusion and Key Research Presentations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHANXBIO-B Shares Surge in Afternoon Trading Following Index Inclusion and Key Research Presentations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-06-24 14:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>HANXBIO-B</b> (<b>HKEX: 03378</b>) rose nearly 7% during the afternoon session. As of the latest update, the stock was up 6.99% to HK$28.48, with a turnover of HK$9.56 million.<br><br>The upward movement follows recent company announcements. <b>HANXBIO-B</b> disclosed that, based on the quarterly review results for the FTSE Global Equity Index Series by FTSE Russell, the company has been added to the FTSE Global Micro Cap Index. This inclusion officially took effect after the market close on Friday, June 19, 2026.<br><br>Prior to this development, <b>HANXBIO-B</b> presented four key preclinical research findings at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The showcased research included the CTLA-4/SIRPα bifunctional fusion protein HX044, the bispecific antibody-drug conjugate (BsAbADC) HX116, the PD-L1-targeting ADC HX112, and a 3D tumor organoid ADC evaluation platform. These presentations further demonstrated the company's research and development capabilities and innovative potential.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"","article_id":"1147220059","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147220059","pubTimestamp":1782280941,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of HANXBIO-B (HKEX: 03378) rose nearly 7% during the afternoon session. As of the latest update, the stock was up 6.99% to HK$28.48, with a turnover of HK$9.56 million.The upward movement...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK1535":"港口运输股","BK4585":"ETF&股票定投概念","VXUS":"国际股票ETF-Vanguard","BK1173":"海港与服务","03378":"翰思艾泰-B","BK1161":"生物科技"},"translate_title":"指数纳入和关键研究报告后，HANXBIO-B股价在下午交易中飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03378":1,"VXUS":1},"content_text":"Shares of HANXBIO-B (HKEX: 03378) rose nearly 7% during the afternoon session. As of the latest update, the stock was up 6.99% to HK$28.48, with a turnover of HK$9.56 million.The upward movement follows recent company announcements. HANXBIO-B disclosed that, based on the quarterly review results for the FTSE Global Equity Index Series by FTSE Russell, the company has been added to the FTSE Global Micro Cap Index. This inclusion officially took effect after the market close on Friday, June 19, 2026.Prior to this development, HANXBIO-B presented four key preclinical research findings at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The showcased research included the CTLA-4/SIRPα bifunctional fusion protein HX044, the bispecific antibody-drug conjugate (BsAbADC) HX116, the PD-L1-targeting ADC HX112, and a 3D tumor organoid ADC evaluation platform. These presentations further demonstrated the company's research and development capabilities and innovative potential.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}